Cargando…
Human T Cell Leukemia Virus Reactivation with Progression of Adult T-Cell Leukemia-Lymphoma
BACKGROUND: Human T-cell leukemia virus-associated adult T-cell leukemia-lymphoma (ATLL) has a very poor prognosis, despite trials of a variety of different treatment regimens. Virus expression has been reported to be limited or absent when ATLL is diagnosed, and this has suggested that secondary ge...
Autores principales: | Ratner, Lee, Harrington, William, Feng, Xuan, Grant, Christian, Jacobson, Steve, Noy, Ariela, Sparano, Joseph, Lee, Jeannette, Ambinder, Richard, Campbell, Nancy, Lairmore, Michael, for the AIDS Malignancy Consortium |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636875/ https://www.ncbi.nlm.nih.gov/pubmed/19204798 http://dx.doi.org/10.1371/journal.pone.0004420 |
Ejemplares similares
-
Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015) -
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
por: Ratner, L, et al.
Publicado: (2016) -
Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma
por: Sparano, Joseph A., et al.
Publicado: (2020) -
Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma
por: Barta, Stefan K, et al.
Publicado: (2010) -
Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment
por: Ratner, Lee
Publicado: (2019)